Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of disease
Authors:
- 1 December 1993
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical and Laboratory Research
- Vol. 23 (1-4) , 34-37
Abstract
The CD25 molecule, which corresponds to the p55 α chain of the interleukin-2 receptors, is strongly expressed by neoplastic cells in hairy-cell leukemia and is released in large amounts in the soluble form which is detectable in serum. In order to assess the reliability of the soluble interleukin-2 receptor as a disease marker in the management of patients with hairy-cell leukemia, we investigated serum levels in 35 untreated patients and in 2 patients with the hairy-cell leukemia variant. In 21 of 35 patients soluble receptor levels were also monitored during and after recombinant interferon-α therapy. Clinical and hematological parameters were also assessed. Soluble interleukin-2 receptor levels were extremely high at the time of diagnosis in patients with typical hairy-cell leukemia [32,722±27,001 vs. 331±145 units/ml in controls (mean±SD)], but not in patients with the leukemia variant. A progressive decrease in soluble interleukin-2 receptor levels paralleled the clinical response to treatment, although normal values were never detected, even in patients who achieved an apparent complete remission. After recombinant interferon-α discontinuation, disease recurrence was accompanied by a progressive increase to pre-treatment soluble receptor levels. Overall, a close correlation was found between soluble interleukin-2 receptor values and total tumor burden (r=0.84,P<0.001). On the basis of these data, soluble interleukin-2 receptor should be regarded as a key marker in the management of patients with hairy-cell leukemia.Keywords
This publication has 19 references indexed in Scilit:
- High Serum Levels of Soluble Interleukin-2 Receptor and Absence of Detectable Levels of Soluble CD30 Molecule: A Specific Diagnostic Combination for Hairy Cell LeukemiaLeukemia & Lymphoma, 1992
- Hairy cell leukaemia: review of treatmentBritish Journal of Haematology, 1991
- Serum levels of soluble interleukin‐2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulkBritish Journal of Haematology, 1989
- THE SOLUBLE INTERLEUKIN‐2 RECEPTOR IN HAEMATOLOGICAL DISORDERSBritish Journal of Haematology, 1987
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- HAIRY-CELL LEUKAEMIABritish Journal of Haematology, 1985
- Routine immunofluorescent and histochemical analysis of bone marrow involvement of lymphoma/leukaemia: The use of cryostat sectionsBritish Journal of Cancer, 1983
- Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.Proceedings of the National Academy of Sciences, 1983
- A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemiaLeukemia Research, 1980
- Hairy Cell LeukemiaAnnals of Internal Medicine, 1978